Sociedad Americana de Hirudoterapia

Near infra-red spectroscopy: a non-invasive monitor of perfusion and oxygenation within the microcirculation of limbs and flaps.

Research article published in British journal of plastic surgery (1995)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Preclinical (animal)Ensayos clínicosIrwin et al. · British journal of plastic surgery, 1995

Abstract

Reliable early detection of adverse circulatory changes within a flap following free tissue transfer and early re-exploration are vital to minimise flap failure. Most surgeons rely on clinical assessment to monitor these changes but techniques such as plethysmography and laser Doppler have their advocates. These methods are limited however to measuring changes close to the surface. Near infra-red spectroscopy (NIRS) is a relatively new, non-invasive technique which allows continuous monitoring of concentration changes in oxy-, deoxy- and total haemoglobin (HbO2, Hb and HbT), as well as oxidised cytochrome aa3, through tissue up to 10 cm in depth. Information is provided on tissue oxygen supply, cellular oxygen utilisation, blood volume and perfusion status. A study has been performed in 10 rabbit hind limbs to assess the ability of NIRS to detect and distinguish between venous, arterial and total vascular occlusion. Clear patterns of change have been identified which allow rapid detection of vascular occlusion with accurate prediction of site. Arterial occlusions were characterised by an increase in Hb with a corresponding decrease in HbO2 and HbT. Venous occlusions resulted in an increase in HbT with relatively minor fluctuations in Hb and HbO2. Simultaneous occlusion of both artery and vein produced similar changes to those of arterial occlusion except that HbT decreased only minimally. These findings suggest that NIRS has a potentially useful role in the monitoring of free flaps, with the great advantage that perfusion can be measured to a considerable depth and information provided on the oxygenation profiles both accurately and non-invasively.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsBlood VolumeFemaleGraft Occlusion, VascularHemoglobinsHindlimbMicrocirculationOxygenOxyhemoglobinsRabbitsSpectrophotometry, InfraredSurgical Flaps

Resumen

Reliable early detection of adverse circulatory changes within a flap following free tissue transfer and early re-exploration are vital to minimise flap failure. Most surgeons rely on clinical assessment to monitor these changes but techniques such as plethysmography and laser Doppler have their advocates.

Por qué esto importa para la hirudoterapia

Este estudio evaluó la espectroscopia de infrarrojo cercano (NIRS) como monitorización no invasiva de la perfusión y la oxigenación en 10 extremidades posteriores de conejo, informando de patrones distintos para la oclusión arterial (aumento de la desoxihemoglobina con disminución de la oxihemoglobina y la hemoglobina total) y la oclusión venosa (aumento de la hemoglobina total), siendo posible la monitorización a través de tejido de hasta 10 cm. El resumen sugiere que la NIRS puede ayudar a monitorizar colgajos libres y detectar la oclusión vascular tras la transferencia tisular. Sin embargo, se trata de un estudio en animales de una tecnología de monitorización y no menciona sanguijuelas, hirudoterapia ni el secretoma de la sanguijuela. Por lo tanto, no aporta evidencia directa sobre la terapia con sanguijuelas y el resumen no respalda ninguna conexión con la hirudoterapia.

Citación

Near infra-red spectroscopy: a non-invasive monitor of perfusion and oxygenation within the microcirculation of limbs and flaps.

Irwin et al. · British journal of plastic surgery, 1995

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.